INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 441m ago
HOUSE PTR40m ago
SEC 13F40m ago
ROBINHOOD CHAIN40m ago
Public company

LFCRLIFECORE BIOMEDICAL, INC. \DE\

CIK 0001005286

EDGAR filingsOpen in network
Disclosed transactions4
Buys / sells0 / 0
Max Insider Score21
Connections4with evidence

LFCR · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
21
JH
Johnson Paul HaroldDirector
LFCRLIFECORE BIOMEDICAL, INC. \DE\
Grant or award
A—
25.9K sh
Jun 4, 2026Jun 5, 2026
traded Jun 4, 2026
+1dSEC FORM 4

Evidence

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 2834 · Pharmaceutical Preparations · Nov 4, 2026
  • ← Insider ofevidence
    Johnson Paul HaroldDirector · Jun 5, 2026
  • ← Insider ofevidence
    Josephs PaulDirector, Chief Executive Officer · May 21, 2026
  • ← Insider ofevidence
    Salus Thomas D.Chief Legal & Administration · Mar 2, 2026
16
JP
Josephs PaulDirector, Chief Executive Officer
LFCRLIFECORE BIOMEDICAL, INC. \DE\
Tax withholding
F
$185K
40.4K sh
May 20, 2026
May 21, 2026
traded May 20, 2026
+1d
SEC FORM 4

Evidence

16
SD
Salus Thomas D.Chief Legal & Administration
LFCRLIFECORE BIOMEDICAL, INC. \DE\
Tax withholding
F$128K
24.6K sh
Apr 14, 2026Apr 16, 2026
traded Apr 14, 2026
+2dSEC FORM 4

Evidence

13
SD
Salus Thomas D.Chief Legal & Administration
LFCRLIFECORE BIOMEDICAL, INC. \DE\
Grant or award
A—
30.0K sh
Mar 2, 2026Mar 2, 2026
traded Mar 2, 2026
+0dSEC FORM 4

Evidence